Abbott Laboratories Officer Files Form 144 for Minor Share Sale
ABBOTT LABORATORIES
Subscribe to track ABT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Notice of Proposed Sale of Securities Issuer: ABBOTT LABORATORIES (ABT) Insider: John A. McCoy, Jr. (Officer) Proposed Sale Amount: 27 shares (~$2,957) Approximate Sale Date: September 2, 2026 Broker: UBS Financial Services, Inc. Significance: Low
Comprehensive Analysis
Executive Summary
On September 2, 2026, John A. McCoy, Jr., an Officer at Abbott Laboratories (NYSE: ABT), filed a Form 144 notice of proposed sale covering 27 shares of common stock with an aggregate market value of approximately $2,957.
Transaction Breakdown
- Securities to be Sold: 27 Common shares
- Estimated Aggregate Market Value: $2,957 (~$109.52 per share)
- Acquisition Source: Restricted Stock Award Vested on September 1, 2026
- Broker: UBS Financial Services, Inc.
- Approximate Sale Date: September 2, 2026
Market & Governance Impact
Given the de minimis size of the transaction (27 shares / $2,957) relative to Abbott's outstanding shares (over 1.73 billion shares), this proposed sale has negligible market impact and represents routine handling of vested equity compensation.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.